Bausch Health Companies Inc. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bausch Health Companies Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Bausch Health Companies Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $318M, a 2171% increase year-over-year.
  • Bausch Health Companies Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $1.35B, a 270% increase year-over-year.
  • Bausch Health Companies Inc. annual Operating Income (Loss) for 2023 was $963M, a 112% increase from 2022.
  • Bausch Health Companies Inc. annual Operating Income (Loss) for 2022 was $454M, a 0.89% increase from 2021.
  • Bausch Health Companies Inc. annual Operating Income (Loss) for 2021 was $450M, a 33.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.35B $318M +$304M +2171% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.05B $389M -$23M -5.58% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.07B $281M +$106M +60.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $963M $362M +$598M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $365M $14M -$230M -94.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $595M $412M +$251M +156% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $344M $175M -$110M -38.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $454M -$236M -$603M -164% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.06B $244M -$330M -57.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.39B $161M +$431M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $956M $285M +$506M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $450M $367M +$372M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $78M $574M +$114M +24.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$36M -$270M -$243M -900% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $207M -$221M -$469M -189% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $676M -$5M +$1.07B +99.5% Oct 1, 2020 Dec 31, 2020 8-K 2021-05-04
Q3 2020 -$395M $460M +$131M +39.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$526M -$27M -$284M -111% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$242M $248M -$39M -13.6% Jan 1, 2020 Mar 31, 2020 8-K 2021-05-04
Q4 2019 -$203M -$1.08B -$1.1B -4404% Oct 1, 2019 Dec 31, 2019 8-K 2021-05-04
Q3 2019 $898M $329M +$212M +181% Jul 1, 2019 Sep 30, 2019 8-K 2021-05-04
Q2 2019 $686M $257M +$502M Apr 1, 2019 Jun 30, 2019 8-K 2021-05-04
Q1 2019 $184M $287M +$2.57B Jan 1, 2019 Mar 31, 2019 8-K 2021-05-04
Q4 2018 -$2.38B $25M +$347M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-19
Q3 2018 -$2.73B $117M +$79M +208% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-19
Q2 2018 -$2.81B -$245M -$420M -240% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-19
Q1 2018 -$2.39B -$2.28B -$2.49B -1181% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-19
Q4 2017 $102M -$322M -$472M -315% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-20
Q3 2017 $574M $38M +$901M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-20
Q2 2017 -$327M $175M +$94M +116% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-20
Q1 2017 -$421M $211M +$145M +220% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-20
Q4 2016 -$566M $150M -$18M -10.7% Oct 1, 2016 Dec 31, 2016 8-K 2018-08-10
Q3 2016 -$548M -$863M -$1.31B -293% Jul 1, 2016 Sep 30, 2016 8-K 2018-08-10
Q2 2016 $763M $81M -$261M -76.3% Apr 1, 2016 Jun 30, 2016 8-K 2018-08-10
Q1 2016 $1.02B $66M -$503M -88.4% Jan 1, 2016 Mar 31, 2016 8-K 2018-08-10
Q4 2015 $1.53B $168M -$449M -72.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 $1.98B $448M -$224M -33.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 $2.2B $342M -$13.1M -3.69% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 $2.21B $569M +$212M +59.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 $2B $617M +$394M +176% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-29
Q3 2014 $1.61B $672M +$1.56B Jul 1, 2014 Sep 30, 2014 10-K 2016-04-29
Q2 2014 $43.7M $355M +$214M +151% Apr 1, 2014 Jun 30, 2014 10-K 2016-04-29
Q1 2014 -$170M $357M +$240M +205% Jan 1, 2014 Mar 31, 2014 10-K 2016-04-29
Q4 2013 -$410M $224M +$322M Oct 1, 2013 Dec 31, 2013 10-K 2016-04-29
Q3 2013 -$731M -$892M -$921M -3126% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $190M $142M +$54.7M +63% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $135M $117M +$55.5M +90.3% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $79.7M -$98.1M -$92.5M -1649% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $172M $29.5M -$82.9M -73.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-01
Q2 2012 $255M $86.8M -$31.7M -26.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $287M $61.5M -$13.2M -17.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $300M -$5.61M +$43.3M +88.5% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $257M $112M +$239M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-05
Q2 2011 $17.9M $118M +$69.7M +143% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$51.7M $74.7M +$58.4M +357% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q4 2010 -$110M -$49M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 -$126M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $48.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $16.4M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.